Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intellia Therapeutics Inc buy DomRuinart

Start price
€53.20
24.03.21 / 50%
Target price
€60.00
24.03.22
Performance (%)
30.86%
End price
€69.62
06.04.21
Summary
This prediction ended on 06.04.21 with a price of €69.62. With a performance of 30.86% the BUY prediction by DomRuinart was a big success. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Intellia Therapeutics Inc 21.748% 21.748% -35.971% -78.087%
iShares Core DAX® 1.776% 3.175% 14.882% 17.660%
iShares Nasdaq 100 -1.037% 1.869% 35.463% 52.324%
iShares Nikkei 225® -0.335% 3.857% 14.485% 11.459%
iShares S&P 500 0.854% 2.567% 31.105% 47.441%

According to DomRuinart what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 30.86%
Target price 60.000
Change
Ends at 24.03.22

Buy mit Kursziel 60,0

In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) 30.86%
Target price 60.000
Change
Ends at 24.03.22

Buy beendet

Stopped prediction by DomRuinart for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€69.62
06.04.21
€80.00
06.04.22
-17.38%
19.04.21

Could be worthwhile Investment >10% per year